Gambro recalls blood tubing after two deaths
This article was originally published in Clinica
Gambro Healthcare has recalled three lots of COBE Centrysystem 3 blood tubing used in dialysis treatment, following the death of two patients in the US. The product recall is restricted to the US.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.